Brain Stimulation Collaboratory Develops New Alzheimer’s Care Models

The Brain Stimulation Collaboratory represents a significant shift in how clinicians approach Alzheimer's disease care.

The Brain Stimulation Collaboratory represents a significant shift in how clinicians approach Alzheimer's disease care.

Artificial intelligence is now detecting Alzheimer's disease with unprecedented accuracy. Recent breakthroughs have achieved classification rates as high...

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has rejected Eli Lilly's Kisunla (donanemab), signaling a...

The Atlanta Neuroscience Institute and the Alzheimer's Association–Atlanta Chapter have launched a partnership that brings structured, expert-led...

Yes, multiple university laboratories across the United States have developed promising Alzheimer's treatment approaches in 2026, with some showing...

Recent patient data confirms what researchers hoped: people are staying on approved Alzheimer's treatments at meaningful rates, and real-world...

Three new blood tests for Alzheimer's disease have received FDA clearance in recent months, marking a significant shift in how physicians can diagnose the...

Harvard researchers are genuinely optimistic about the future of Alzheimer's care, and their confidence is grounded in measurable scientific progress.

Catalyst MedTech announced on March 25, 2026 that it is establishing the full national deployment of its Full Access Neurology solution as the industry...

PET (positron emission tomography) scans have become one of the most effective tools for detecting Alzheimer's disease in its earliest stages, often...
HelpDementia.com
Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance
© 2026 HelpDementia.com. All rights reserved.
Educational information only. It is not medical advice and does not replace care from a qualified clinician.